ENST00000481673.5:n.1846T>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The ENST00000481673.5(CHKB):​n.1846T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00416 in 618,208 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0047 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 9 hom. )

Consequence

CHKB
ENST00000481673.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.100

Publications

0 publications found
Variant links:
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00466 (709/152252) while in subpopulation AFR AF = 0.0071 (295/41542). AF 95% confidence interval is 0.00643. There are 1 homozygotes in GnomAd4. There are 335 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHKBNM_005198.5 linkc.*208T>G 3_prime_UTR_variant Exon 11 of 11 ENST00000406938.3 NP_005189.2 Q9Y259-1A0A024R4X4
CHKB-CPT1BNR_027928.2 linkn.1551+63T>G intron_variant Intron 11 of 29

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHKBENST00000406938.3 linkc.*208T>G 3_prime_UTR_variant Exon 11 of 11 1 NM_005198.5 ENSP00000384400.3 Q9Y259-1
CHKB-CPT1BENST00000453634.5 linkn.*145+63T>G intron_variant Intron 3 of 22 5 ENSP00000457031.1 H3BT56

Frequencies

GnomAD3 genomes
AF:
0.00466
AC:
709
AN:
152134
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00710
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00492
Gnomad OTH
AF:
0.00335
GnomAD4 exome
AF:
0.00400
AC:
1865
AN:
465956
Hom.:
9
Cov.:
4
AF XY:
0.00404
AC XY:
998
AN XY:
247332
show subpopulations
African (AFR)
AF:
0.0100
AC:
131
AN:
13056
American (AMR)
AF:
0.00228
AC:
53
AN:
23266
Ashkenazi Jewish (ASJ)
AF:
0.00139
AC:
20
AN:
14392
East Asian (EAS)
AF:
0.00156
AC:
48
AN:
30760
South Asian (SAS)
AF:
0.00481
AC:
232
AN:
48220
European-Finnish (FIN)
AF:
0.000294
AC:
10
AN:
34002
Middle Eastern (MID)
AF:
0.00451
AC:
9
AN:
1994
European-Non Finnish (NFE)
AF:
0.00461
AC:
1262
AN:
274022
Other (OTH)
AF:
0.00381
AC:
100
AN:
26244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
101
202
302
403
504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00466
AC:
709
AN:
152252
Hom.:
1
Cov.:
33
AF XY:
0.00450
AC XY:
335
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00710
AC:
295
AN:
41542
American (AMR)
AF:
0.00301
AC:
46
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5176
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4822
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00493
AC:
335
AN:
68014
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
35
70
104
139
174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00476
Hom.:
1
Bravo
AF:
0.00486
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Megaconial type congenital muscular dystrophy Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
4.1
DANN
Benign
0.79
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41281533; hg19: chr22-51017402; API